SCHEMBL2956347

SCHEMBL2956347

O=C1CC(O)(Cl)C(=O)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
RECQL P46063 3/20 0.50
ALOX12 P18054 2/20 0.50
EHMT2 Q96KQ7 2/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
CASP1 P29466 1/20 0.50
CA7 P43166 1/20 0.50
BACE1 P56817 1/20 0.50
CA9 Q16790 1/20 0.50
POLB P06746 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
S100A4 P26447 2/20 0.42
GFER P55789 1/20 0.40
MAPT P10636 6/20 0.39
APAF1 O14727 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7760631 0.81 MEN1 (0.47) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL2724212 0.79 ALDH1A1 (0.54) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL8895118 0.76 S100A4 (0.47) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL25835259 0.76 POLB (0.51) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL12822665 0.76 POLB (0.51) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL25835313 0.73 ALDH1A1 (0.47) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL29244104 0.71 KMT2A (0.46) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL28680129 0.71 POLB (0.54) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL21646073 0.69 HTT (0.49) ALDH1A1L3MBTL1RECQLALOX12EHMT2
SCHEMBL28357232 0.68 MAPT (0.44) ALDH1A1L3MBTL1RECQLALOX12EHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231146-A2 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GLAUCOMA Mazence Inc. (KR) 2010-09-29 EP disclosed
WO-2009082124-A2 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GLAUCOMA MAZENCE INC. (KR) 2009-07-02 WO disclosed